Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1822]

Results from the EMN-011 trial, combination therapy for multiple myeloma

Prof Pieter Sonneveld - Erasmus MC Cancer Institute, Rotterdam, Netherlands

Results from the EMN-011 trial, combination therapy for multiple myeloma ( Prof Pieter Sonneveld - Erasmus MC Cancer Institute, Rotterdam, Netherlands )

Circulating tumour-cell count used to decide between treatments for breast...

Dr Francois-Clement Bidard - Institut Curie, Paris, France

Circulating tumour-cell count used to decide between treatments for breast cancer patients ( Dr Francois-Clement Bidard - Institut Curie, Paris, France )

Adjuvant capecitabine did not significantly improve outcomes for breast cancer...

Dr Miguel Martín - Universidad Complutense de Madrid, Madrid, Spain

Adjuvant capecitabine did not significantly improve outcomes for breast cancer patients ( Dr Miguel Martín - Universidad Complutense de Madrid, Madrid, Spain )

Substituting trastuzumab emtansine for adjuvant trastuzumab improved IDFS for...

Prof Charles Geyer - Allegheny General Hospital, Pittsburgh, USA

Substituting trastuzumab emtansine for adjuvant trastuzumab improved IDFS for breast cancer patients ( Prof Charles Geyer - Allegheny General Hospital, Pittsburgh, USA )

Role of chemotherapy in the treatment of metastatic breast cancer patients

Professors Joseph Gligorov, Yen-Shen Lu, Chris Twelves and Dr Reshma Mahtani

Role of chemotherapy in the treatment of metastatic breast cancer patients ( Professors Joseph Gligorov, Yen-Shen Lu, Chris Twelves and Dr Reshma Mahtani )

Recent data on eribulin in metastatic breast cancer patients from SABCS 2018

Professor Chris Twelves and Dr Giampaolo Bianchini

Recent data on eribulin in metastatic breast cancer patients from SABCS 2018 ( Professor Chris Twelves and Dr Giampaolo Bianchini )

The combined analysis of carfilzomib trials for multiple myeloma

Prof Maria-Victoria Mateos - University of Salamanca, Salamanca, Spain

The combined analysis of carfilzomib trials for multiple myeloma ( Prof Maria-Victoria Mateos - University of Salamanca, Salamanca, Spain )

Gilteritinib combined with induction and consolidation chemotherapy in newly...

Dr Keith Pratz - Johns Hopkins University, Baltimore, USA

Gilteritinib combined with induction and consolidation chemotherapy in newly diagnosed AML patients ( Dr Keith Pratz - Johns Hopkins University, Baltimore, USA )

Results from RIALTO, blinatumomab for paediatric patients with B-cell precursor...

Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy

$Results from RIALTO, blinatumomab for paediatric patients with B-cell precursor relapsed/refractory ALL ( Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy )$

Ibrutinib and rituximab provides superior PFS and OS compared to FCR for...

Dr Tait Shanafelt - Standford University, Stanford, USA

Ibrutinib and rituximab provides superior PFS and OS compared to FCR for younger patients with previously untreated CLL ( Dr Tait Shanafelt - Standford University, Stanford, USA )

Patient treatment preferences in relapsed/refractory multiple myeloma

Dr Joseph Mikhael, Prof James Chim and Prof Evangelos Terpos

$Patient treatment preferences in relapsed/refractory multiple myeloma ( Dr Joseph Mikhael, Prof James Chim and Prof Evangelos Terpos )$

Landscape change with oral proteasome maintenance in multiple myeloma patients

Prof Maria-Victoria Mateos, Prof Wee Joo Chng, Prof Meral Beksac and Dr Sagar...

Landscape change with oral proteasome maintenance in multiple myeloma patients ( Prof Maria-Victoria Mateos, Prof Wee Joo Chng, Prof Meral Beksac and Dr Sagar Lonial )

More from ecancer